DAFNA Capital Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-576,881
| Closed | -$3.65M | – | 81 |
|
|
2022
Q4 | $3.65M | Hold |
576,881
| – | – | 1.03% | 30 |
|
|
2022
Q3 | $2.95M | Hold |
576,881
| – | – | 0.79% | 34 |
|
|
2022
Q2 | $3.61M | Sell |
576,881
-116,904
| -17% | -$732K | 0.98% | 33 |
|
|
2022
Q1 | $2.46M | Hold |
693,785
| – | – | 0.64% | 44 |
|
|
2021
Q4 | $3.48M | Hold |
693,785
| – | – | 0.88% | 31 |
|
|
2021
Q3 | $5.08M | Sell |
693,785
-20,500
| -3% | -$150K | 1.35% | 20 |
|
|
2021
Q2 | $6.14M | Buy |
+714,285
| New | +$6.14M | 1.28% | 22 |
|
|
2017
Q4 | – | Sell |
-1,627
| Closed | -$110K | – | 79 |
|
|
2017
Q3 | $110K | Buy |
1,627
+1,227
| +307% | +$83K | 0.07% | 70 |
|
|
2017
Q2 | $217K | Buy |
+400
| New | +$217K | 0.15% | 66 |
|
|
2017
Q1 | – | Sell |
-6,853
| Closed | -$219K | – | 78 |
|
|
2016
Q4 | $219K | Buy |
+6,853
| New | +$219K | 0.19% | 61 |
|